ROCHESTER, Mich. , March 14, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, announced today that its Board of Directors has unanimously authorized a share repurchase
Deal will enable high-growth patient services company to streamline and enhance its services with OptimizeRx’s technology solutions ROCHESTER, Mich. , March 09, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions
Q4 revenue of $19.7 million , down 3% year-over-year and up 30% quarter-over-quarter Q4 gross profit increased 1% year-over-year to $12.5 million as gross margins increased from 61% to 63% Generated $10.7 million in cash flow from operations in 2022 Repurchased 1.2 million shares during 2022 at an
ROCHESTER, Mich. , Feb. 23, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, will hold a conference call on Wednesday, March 8, 2023 at 4:30 p.m.
ROCHESTER, Mich. , Feb. 09, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, today announced its senior vice president of access and adherence, Karina Castagna , has been
OPRX CEO Will Febbo provides business update and key industry trends OPRX conference presentation to begin at 8:15 AM PT on January 12, 2023 ROCHESTER, Mich. , Jan. 04, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology
ROCHESTER, Mich. , Nov. 28, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, today announced that management will participate in the following upcoming investor
Q3 Revenue of $15.1 million , down 6% year-over-year and up 8% quarter-over-quarter Gross profit increased 4% year-over-year to $9.4 million as gross margins increased from 56% to 62% Generated $7.9 million in cash flow from operations during the first nine months of 2022 Repurchased 1.1 million
Virtual event takes place December 1, 2022 ROCHESTER, Mich. , Oct. 20, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, today announced the third annual Innovate4Outcomes ®
ROCHESTER, Mich. , Oct. 19, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, will hold a conference call on Tuesday, November 8, 2022, at 4:30 p.m.
